Press release
CRISPR Pipeline, Clinical Trials Studies, Agreements & Collaborations, and Latest News 2023 (Updated)
CRISPR Pipeline
Key Takeaways from the CRISPR Pipeline Report
• DelveInsight's CRISPR pipeline report depicts a robust space with 25+ active players working to develop 30+ pipeline therapies for CRISPR treatment.
• The leading companies working in the CRISPR Market include Intima Bioscience Inc., Masonic Cancer Center, Shanghai BDgene Co. Ltd., HuidaGene Therapeutics Co., Ltd., Caribou Biosciences Inc., Vertex Pharmaceuticals Incorporated, CRISPR Therapeutics, EdiGene Inc., Excision Bio Therapeutics, ICON Clinical Research, MRI Global, Editas Medicine Inc., Chengdu MedGenCell Co. Ltd., Intellia Therapeutics, and others.
• Promising CRISPR Pipeline Therapies in the various stages of development include Cyclophosphamide, Fludarabine, Aldesleukin, BD111 Adult single group Dose, HG202, CB-011, VGB-Ex01, CTX001, and others.
• September 2023: Intellia Therapeutics announced a study of phase 1 clinical trials for NTLA-2001. This study will be conducted to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of NTLA-2001 in participants with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) and participants with hereditary transthyretin amyloidosis with cardiomyopathy (ATTRv-CM) or wild type cardiomyopathy (ATTRwt-CM)
• October 2023: Editas Medicine Inc. announced a study of phase 1 & 2 clinical trials for EDIT-301. The purpose of this study is to evaluate the safety, tolerability, and efficacy of treatment with EDIT-301 in adult participants with Transfusion Dependent beta Thalassemia.
Request a sample and discover the recent advances in CRISPR Treatment Drugs @ CRISPR Pipeline Report- https://www.delveinsight.com/report-store/crispr-therapies-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
In the CRISPR pipeline report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, CRISPR NDA approvals (if any), and product development activities comprising the technology, CRISPR Therapies collaborations, licensing, mergers and acquisition, funding, designations and other product related details.
CRISPR Overview
CRISPRs are specialized stretches of DNA. ""CRISPR"" stands for ""clusters of regularly interspaced short palindromic repeats."" It is a specialized region of DNA with two distinct characteristics: the presence of nucleotide repeats and spacers. Repeated sequences of nucleotides - the building blocks of DNA - are distributed throughout a CRISPR region.
Find out more about CRISPR Therapeutics Assessment @ CRISPR Preclinical and Discovery Stage Products- https://www.delveinsight.com/sample-request/crispr-therapies-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
CRISPR Emerging Drugs Profile
• CTX001: CRISPR Therapeutics
• EDIT-101: Editas Medicine
CRISPR Pipeline Therapeutics Assessment
There are approx. 25+ key companies which are developing the CRISPR Therapies. The CRISPR Therapies companies which have their CRISPR Therapies drug candidates in the most advanced stage, i.e. Phase I/II include, CRISPR therapeutics.
CRISPR Pipeline Segmentation
• Late stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I) along with the details of
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Learn more about the emerging CRISPR Pipeline Therapies @ CRISPR Clinical Trials Assessment- https://www.delveinsight.com/sample-request/crispr-therapies-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the CRISPR Pipeline Report
• Coverage- Global
• CRISPR Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• CRISPR Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
• CRISPR Companies- Intima Bioscience Inc., Masonic Cancer Center, Shanghai BDgene Co. Ltd., HuidaGene Therapeutics Co., Ltd., Caribou Biosciences Inc., Vertex Pharmaceuticals Incorporated, CRISPR Therapeutics, EdiGene Inc., Excision Bio Therapeutics, ICON Clinical Research, MRI Global, Editas Medicine Inc., Chengdu MedGenCell Co. Ltd., Intellia Therapeutics, and others.
• CRISPR Pipeline Therapies- Cyclophosphamide, Fludarabine, Aldesleukin, BD111 Adult single group Dose, HG202, CB-011, VGB-Ex01, CTX001, and others.
Dive deep into rich insights for new drugs for CRISPR Treatment, Visit @ CRISPR Market Drivers and Barriers, and Future Perspective- https://www.delveinsight.com/sample-request/crispr-therapies-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. CRISPR Therapies: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Late Stage Products (Phase III)
7. Drug Name: Company Name
8. Drug profiles in the detailed report…..
9. Early Stage Products (Phase I/II)
10. CTX001: CRISPR Therapeutics
11. Drug profiles in the detailed report…..
12. Early stage products (Phase I)
13. LBP-EC01: Locus Biosciences
14. Drug profiles in the detailed report…..
15. Inactive Products
16. CRISPR Therapies Key Companies
17. CRISPR Therapies Key Products
18. CRISPR Therapies- Unmet Needs
19. CRISPR Therapies- Market Drivers and Barriers
20. CRISPR Therapies- Future Perspectives and Conclusion
21. CRISPR Therapies Analyst Views
22. CRISPR Therapies Key Companies
23. Appendix
For further information on the CRISPR Pipeline therapeutics, reach out to CRISPR Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/crispr-therapies-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/consulting/ci-tracking
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CRISPR Pipeline, Clinical Trials Studies, Agreements & Collaborations, and Latest News 2023 (Updated) here
News-ID: 3256351 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for CRISPR
Amerigo Scientific Unveils CRISPR/Cas Enzymes to Expand the CRISPR Toolbox
Amerigo Scientific, as a distributor focused on providing critical products and services to biomedical and life science communities, announced the release of a groundbreaking selection of CRISPR/Cas enzymes to its extensive life science portfolio, aimed at further expanding the vast potential of the CRISPR toolbox. This addition brings cutting-edge genetic editing tools to scientists and researchers in a variety of fields.
CRISPR/Cas (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated) technology revolutionized the…
CRISPR Technology Market - Gene Editing Redefined: Pioneering CRISPR Technology …
Newark, New Castle, USA: The "CRISPR Technology Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
CRISPR Technology Market: https://www.growthplusreports.com/report/crispr-technology-market/7632
This latest report researches the industry structure, sales,…
CRISPR And CRISPR-Associated (Cas) Genes Market Analysis & Trends - Industry For …
LOS ANGELES, United States: The research study presented in this report offers a complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the global CRISPR And CRISPR-Associated (Cas) Genes market. It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global CRISPR And CRISPR-Associated (Cas) Genes market. The authors of the report have segmented…
CRISPR & Cas Genes Market Dynamic Growth Factors 2028 | CRISPR Therapeutics, Ast …
"CRISPR & Cas Genes Market" Report offers an in-depth analysis of the market size, share, SWOT Analysis, future progress expansion, industry growth, key development strategies and market trend dynamics which includes drivers, restraints, opportunities prevailing in the industry by product type, application, key manufacturers and key regions and countries.
It also offers advanced statistics as well as some business-driven information associated with the precise industry. It delivers an analytical investigation of the…
CRISPR and CRISPR-Associated (Cas) Genes Market 2022 | Detailed Report
According to Market Study Report, CRISPR and CRISPR-Associated (Cas) Genes Market provides a comprehensive analysis of the CRISPR and CRISPR-Associated (Cas) Genes Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4240401
The report provides a comprehensive analysis of company profiles listed below:
-…
CRISPR and CRISPR-Associated (Cas) Genes Market 2021 | Detailed Report
The CRISPR and CRISPR-Associated (Cas) Genes research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players. Furthermore, the report offers insightful market data and information about…
